Obesity Management in Cardiometabolic Disease: State of the Art

Sean J. Iwamoto, Layla A. Abushamat, Adnin Zaman, Anthony J. Millard, Marc Andre Cornier*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Purpose of Review: To summarize research from the last 5 years on the effects of weight loss treatments, including lifestyle changes, anti-obesity medications, and bariatric procedures on cardiovascular disease (CVD) risk factors and CVD outcomes in adults. Recent Findings: This narrative review includes and summarizes the contemporary evidence of the effects of these different weight loss approaches individually. A literature search was performed using the key words obesity, weight loss, CVD, cardiometabolic, and risk factors and included key clinical trials from the past 5 years. Obesity management through weight loss is associated with improvements in CVD risk factors, such as improved blood pressure, lipid profiles, and glycemic control, with greater weight loss leading to greater improvements in CVD risk factors. Bariatric surgery is associated with greater weight loss than the other procedures and treatments for obesity, and for this, and possibly for other reasons, it is associated with greater reductions in CVD outcomes and mortality. Summary: Obesity is an independent risk factor and modulator of other CVD risk factors, and thus, treatment of obesity should be an integral part of management strategies to reduce CVD risk. Future trials and real-world studies of longer duration are needed to inform providers and patients on how to individualize the approach to modifying risks of cardiometabolic disorders through obesity management.

Original languageEnglish (US)
Article number59
JournalCurrent atherosclerosis reports
Issue number10
StatePublished - Oct 2021


  • Cardiometabolic
  • Cardiovascular disease
  • Obesity
  • Risk factors
  • Weight loss

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Obesity Management in Cardiometabolic Disease: State of the Art'. Together they form a unique fingerprint.

Cite this